Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 4

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

A Unified Dataset for Antibody and Nanobody Design Including Sequence, Structure, and Binding Affinity Data

Wu, Yikai, Liu, Xuejiao, Hrovatin, Karin, Wu, Dezhi, Linker, Stephanie, Winkel, Mathias, Tan, Feng·2026·Scientific Data

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41597-026-06878-0

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 35

  1. Jin, B.K., Odongo, S., Radwanska, M. & Magez, S. NANOBODIES (R): A Review of Diagnostic and Therapeutic Applications. Int J Mol Sci 24 (2023). · DOI · Paper page
  2. Lu, R. M. et al. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci 27, 1 (2020). · DOI · Paper page
  3. Abdolvahab, M. H., Karimi, P., Mohajeri, N., Abedini, M. & Zare, H. Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies. Cancer Cell Int 24, 67 (2024). · DOI
  4. Jovcevska, I. & Muyldermans, S. The Therapeutic Potential of Nanobodies. BioDrugs 34, 11–26 (2020). · DOI · Paper page
  5. Haddad, F., Dokmak, G., Kanwal, S. & Karaman, R. A Comprehensive Review on Therapeutic Potential of Nanobodies. Preprint at https://www.preprints.org/frontend/manuscript/8fc19cbc184efbf3f0096555d235be6f/download_pub (2023).
  6. Panwar, U., Khan, M.A., Selvaraj, C. & Singh, S.K. Therapeutic antibodies against cancer—A step toward the treatment. in Resistance to Anti-CD20 Antibodies and Approaches for Their Reversal 3–29 (2024). · DOI
  7. Sroga, P., Safronetz, D. & Stein, D. R. Nanobodies: A New Approach for the Diagnosis and Treatment of Viral Infectious Diseases. Future Virology 15, 195–205 (2020). · DOI
  8. Felten, R., Mertz, P., Sebbag, E., Scherlinger, M. & Arnaud, L. Novel therapeutic strategies for autoimmune and inflammatory rheumatic diseases. Drug Discov Today 28, 103612 (2023). · DOI
  9. Rizk, S. S., Moustafa, D. M., ElBanna, S. A., Nour El-Din, H. T. & Attia, A. S. Nanobodies in the fight against infectious diseases: repurposing nature’s tiny weapons. World J Microbiol Biotechnol 40, 209 (2024). · DOI
  10. de Brito, P. M., Saruga, A., Cardoso, M. & Goncalves, J. Methods and cell-based strategies to produce antibody libraries: current state. Appl Microbiol Biotechnol 105, 7215–7224 (2021). · DOI
  11. Bai, G. et al. Accelerating antibody discovery and design with artificial intelligence: Recent advances and prospects. Semin Cancer Biol 95, 13–24 (2023). · DOI
  12. Hummer, A. M., Abanades, B. & Deane, C. M. Advances in computational structure-based antibody design. Curr Opin Struct Biol 74, 102379 (2022). · DOI
  13. Callaway, E. How generative AI is building better antibodies. Nature 617, 235–235 (2023).
  14. Olsen, T. H., Boyles, F. & Deane, C. M. Observed Antibody Space: A diverse database of cleaned, annotated, and translated unpaired and paired antibody sequences. Protein Sci 31, 141–146 (2022). · DOI · Paper page
  15. Berman, H. M. et al. The protein data bank. Nucleic acids research 28, 235–242 (2000). · DOI · Paper page
  16. Burley, S. K. et al. RCSB Protein Data Bank (RCSB. org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence/machine learning. Nucleic acids research 51, D488–D508 (2023). · DOI · Paper page
  17. The UniProt, C. UniProt: the universal protein knowledgebase. Nucleic Acids Res 45, D158–D169 (2017). · DOI · Paper page
  18. Schneider, C., Raybould, M. I. J. & Deane, C. M. SAbDab in the age of biotherapeutics: updates including SAbDab-nano, the nanobody structure tracker. Nucleic Acids Res 50, D1368–D1372 (2022). · DOI
  19. Miller, N. L., Clark, T., Raman, R. & Sasisekharan, R. Learned features of antibody-antigen binding affinity. Front Mol Biosci 10, 1112738 (2023). · DOI
  20. Tsuruta, H. et al. AVIDa-hIL6: a large-scale VHH dataset produced from an immunized alpaca for predicting antigen-antibody interactions. Advances in Neural Information Processing Systems 36, 42077–42096 (2023).
  21. Shanehsazzadeh, A. et al. Unlocking de novo antibody design with generative artificial intelligence. BioRxiv, 2023.01. 08.523187 (2023).
  22. Perron, M. D. et al. Allosteric noncompetitive small molecule selective inhibitors of CD45 tyrosine phosphatase suppress T-cell receptor signals and inflammation in vivo. Molecular pharmacology 85, 553–563 (2014). · DOI
  23. Michalewicz, K., Barahona, M. & Bravi, B. ANTIPASTI: Interpretable prediction of antibody binding affinity exploiting normal modes and deep learning. Structure 32, 2422–2434. e5 (2024). · DOI
  24. Gottlieb, A., Stein, G. Y., Oron, Y., Ruppin, E. & Sharan, R. INDI: a computational framework for inferring drug interactions and their associated recommendations. Molecular systems biology 8, 592 (2012). · DOI · Paper page
  25. Abanades, B. et al. The Patent and Literature Antibody Database (PLAbDab): an evolving reference set of functionally diverse, literature-annotated antibody sequences and structures. Nucleic Acids Research 52, D545–D551 (2024). · DOI
  26. Sirin, S., Apgar, J. R., Bennett, E. M. & Keating, A. E. AB-Bind: Antibody binding mutational database for computational affinity predictions. Protein Science 25, 393–409 (2016). · DOI · Paper page
  27. Ma, Y., Yu, D., Wu, T. & Wang, H. PaddlePaddle: An open-source deep learning platform from industrial practice. Frontiers of Data and Domputing 1, 105–115 (2019).
  28. DeOnna, J. DACUM: A versatile competency-based framework for staff development. Journal for Nurses in Professional Development 18, 5–11 (2002). · DOI
  29. Yue, Y. et al. MpbPPI: a multi-task pre-training-based equivariant approach for the prediction of the effect of amino acid mutations on protein–protein interactions. Briefings in Bioinformatics 24, bbad310 (2023). · DOI
  30. Su, M. et al. Comparative assessment of scoring functions: the CASF-2016 update. Journal of chemical information and modeling 59, 895–913 (2018). · DOI · Paper page
  31. Giudicelli, V. & Lefranc, M. P. IMGT-ONTOLOGY 2012. Front. Genet. 3, 79 (2012). · doi:10.3389/fgene.2012.00079
  32. Agarwal, A.A. et al. AlphaBind, a domain-specific model to predict and optimize antibody–antigen binding affinity. in Mabs 17 2534626 (Taylor & Francis, 2025). · DOI · Paper page
  33. Luo, S. et al. Antigen-specific antibody design and optimization with diffusion-based generative models for protein structures. Advances in Neural Information Processing Systems 35, 9754–9767 (2022).
  34. Shrestha, P. et al. NanoBinder: a machine learning assisted nanobody binding prediction tool using Rosetta energy scores. Journal of Cheminformatics 17, 96 (2025). · DOI
  35. Prihoda, D. et al. BioPhi: A platform for antibody design, humanization, and humanness evaluation based on natural antibody repertoires and deep learning. in MAbs 14 2020203 (Taylor & Francis, 2022). · DOI · Paper page

Metadata

Authors
Wu, Y., Liu, X., Hrovatin, K., Wu, D., Linker, S., Winkel, M., & Tan, F.
Venue
Scientific Data
Published
2026-02-21
Volume
13
Issue
1
ISSN
2052-4463
Cited by
4
References
9
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Unified Dataset for Antibody and Nanobody Design Including Sequence, Structure, and Binding Affinity Data. https://app.cochat.ai/papers/10.1038/s41597-026-06878-0
The paper
Wu, Y., Liu, X., Hrovatin, K., Wu, D., Linker, S., Winkel, M., & Tan, F. (2026). A Unified Dataset for Antibody and Nanobody Design Including Sequence, Structure, and Binding Affinity Data. Scientific Data. https://doi.org/10.1038/s41597-026-06878-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.